HIMSS 2023: Dr. Robert Berube to Highlight Tech-Enabled 13,000 Patient Engagement Case Study

HIMSS Global Health Conference to Examine Digital Solutions for Improved Care/Health Management

Newark, DE (March 30, 2023): Dr. Robert Berube, co-founder of 5thPort, a DecisivEdge company, will be speaking at HIMSS Global Health Conference & Exhibition about the advantages of cloud-based digital patient engagement and e-Consent technology..

The Healthcare Information and Management Systems Society, Inc. (HIMSS) Conference, to be held April 17-21 in Chicago, is recognized as the most influential health information technology event of the year with an anticipated attendance of over 40,000+. One of the premier session topics is Technology, a host of sessions focused on current and emerging digital health solutions and user experiences.

In one of the sessions, Dr. Berube will be speaking about a recent patient engagement study that evaluated the benefits of technology to his practice, patients and overall services. In 2019, Dr. Berube implemented the 5thPort cloud-based digital patient engagement and e-consent solution at his oral and maxillofacial surgical center. This platform is purpose built to help healthcare organizations facilitate patient and administrative experiences through a standardized, centralized, documented and efficient workflow. It includes customizable video/text-based patient education forms in highly documented, interactive formats including video-education modules, comprehension-testing, teach-back learning, digital informed consent, digital document management and patient survey capabilities.

As a test of the e-Consent platform’s capabilities and value, Dr. Berube evaluated over 13,000 surgical and anesthesia patient experiences over the course of four years. In the presentation at HIMSS, he will highlight the implementation process as well as the benefits realized in the way of administrative efficiencies, the reduced risk of uninformed patients and the documented improvements in patient experiences. In fact, of the patients surveyed, 96% gave the e-Consent process the highest rating.

Dr. Berube’s session is scheduled for Wednesday, April 19 from 1:45 PM – 2:05 PM CT in the North Building, Level 3, Hall B. As well, 5th Port team will be available to answer any questions or provide demonstrations of the platform at Booth 8300-8313.